Predictive factors for disease progression in moderate to severe COVID-19 patients

被引:0
|
作者
Boubaker, Nouha [1 ]
Louhaichi, Sabrine [1 ]
Khalfallah, Ikbel [1 ]
Belkhir, Safa [1 ]
Ferchichi, Mariem [1 ]
Ammar, Jamel [1 ]
Hamdi, Besma [1 ]
Hamzaoui, Agnes [1 ]
机构
[1] Abderrahmen Mami Hosp, Ariana, Tunisia
关键词
Covid-19; Comorbidities;
D O I
10.1183/13993003.congress-2021.PA809
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA809
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Prevalence and predictive value of hypocalcemia in severe COVID-19 patients
    Liu, Jingmei
    Han, Ping
    Wu, Jingwen
    Gong, Jin
    Tian, Dean
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (09) : 1224 - 1228
  • [42] Are CLD Patients at increased Risk for severe COVID-19 Progression?
    Metzger, Leandra
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (12): : 1258 - +
  • [43] Persistent reduction of retinal microvascular vessel density in patients with moderate and severe COVID-19 disease
    Garcia, Sandra Banderas
    Aragon, David
    Azarfane, Brahim
    Trejo, Fernando
    Garrell-Salat, Xavier
    Sanchez-Montalva, Adrian
    Otero-Romero, Susana
    Garcia-Arumi, Jose
    Zapata, Miguel Angel
    [J]. BMJ OPEN OPHTHALMOLOGY, 2022, 7 (01):
  • [44] Interferon β-1b for patients with moderate to severe COVID-19 in the inflammatory phase of the disease
    Tortajada, Cecilia
    Anon, Sol
    Ortiz, Maria Milagros
    Andreu-Ballester, Juan Carlos
    Flores, Juan
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (07) : 4102 - 4107
  • [45] MicroRNAs and cytokines as potential predictive biomarkers for COVID-19 disease progression
    Hatem A. Mohamed
    Aya Eid Abdelkafy
    Rasha M. M. Khairy
    Salama R. Abdelraheim
    Bothina Ahmed Kamel
    Heba Marey
    [J]. Scientific Reports, 13
  • [46] MicroRNAs and cytokines as potential predictive biomarkers for COVID-19 disease progression
    Mohamed, Hatem A.
    Abdelkafy, Aya Eid
    Khairy, Rasha M. M.
    Abdelraheim, Salama R.
    Kamel, Bothina Ahmed
    Marey, Heba
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [47] Clinical characteristics and prognostic factors of COVID-19 patients progression to severe: a retrospective, observational study
    Liao, Yunfei
    Feng, Yong
    Wang, Bo
    Wang, Hanyu
    Huang, Jinsha
    Wu, Yaxin
    Wu, Ziling
    Chen, Xiao
    Yang, Chao
    Fu, Xinqiao
    Sun, Hui
    [J]. AGING-US, 2020, 12 (19): : 18853 - 18865
  • [48] Adrenomedullin Therapy in Moderate to Severe COVID-19
    Kita, Toshihiro
    Kitamura, Kazuo
    [J]. BIOMEDICINES, 2022, 10 (03)
  • [49] Inflammation/coagulopathy/fibrinolysis: Dynamic indicators of COVID-19 progression in patients with moderate COVID-19 in Wenzhou, China
    An, Hui
    Zhang, Jitai
    Zhou, Tong
    Li, Ting
    Li, Shan
    Huang, Caili
    Chen, Chengshui
    Ying, Binyu
    Xu, Zhangye
    Jin, Shengwei
    Li, Xiaokun
    Li, Ming
    [J]. CLINICAL IMMUNOLOGY, 2021, 232
  • [50] Olfactory Dysfunction in Mild-Moderate-Severe COVID-19 Patients
    Tuzun, Kemal
    Abes, Derya
    [J]. B-ENT, 2022, 18 (01) : 59 - 66